A study on the clinical efficacy and safety of drug-eluting bead transarterial chemoembolization combined with systemic antitumor regimen in treatment of unresectable primary hepatic carcinoma

LIANG Guo-dong; PENG Yong; CONG Peng

doi:10.3969/j.issn.1674-3806.2023.11.10

Home>Articles>A study on the clinical efficacy and safety of drug-eluting bead transarterial chemoembolization combined with systemic antitumor regimen in treatment of unresectable primary hepatic carcinoma

DOI: 10.3969/j.issn.1674-3806.2023.11.10

A study on the clinical efficacy and safety of drug-eluting bead transarterial chemoembolization combined with systemic antitumor regimen in treatment of unresectable primary hepatic carcinoma

LIANG Guo-dong

PENG Yong

CONG Peng

Keywords：Primary hepatic carcinoma(PHC)Drug-eluting bead transarterial chemoembolization(DEB-TACE)ImmunotherapyTargeted therapy

Publication Date：2023-11-28

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：6( 1153-1158 )

Chinese Journal of New Clinical Medicine

ISTIC

ISSN：1674-3806

Year, Vol.(Issue)：2023,16(11)